Eli Lilly to raise UK price of diabetes drug Mounjaro amid U.S. pressure to cut costs
LONDON: Eli Lilly & Co (LLY.N) said on Thursday it will raise the list price of its diabetes drug Mounjaro in the United Kingdom starting Sept. 1, as former U.S. President Donald Trump intensifies pressure on pharmaceutical companies to lower domestic drug prices and offset costs abroad. The U.S. drugmaker said it reached an agreement…